Next Article in Journal
Ex Vivo Fluorescence Confocal Microscopy for Intraoperative Examinations of Lung Tumors as Alternative to Frozen Sections—A Proof-of-Concept Study
Previous Article in Journal
Shifting from Immunohistochemistry to Screen for ALK Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung Cancer
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Sung et al. Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy. Cancers 2022, 14, 3749

1
Department of Radiation Oncology, Eunpyeong St. Mary’s Hospital, Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea
2
Division of Medical Oncology, Department of Internal Medicine, Eunpyeong St. Mary’s Hospital, Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea
3
Department of Radiation Oncology, Incheon St. Mary’s Hospital, Catholic University of Korea College of Medicine, Seoul 06591, Republic of Korea
4
Department of Surgery, Incheon St. Mary’s Hospital, The Catholic University of Korea, Seoul 06591, Republic of Korea
*
Author to whom correspondence should be addressed.
Cancers 2024, 16(12), 2220; https://doi.org/10.3390/cancers16122220
Submission received: 20 May 2024 / Accepted: 22 May 2024 / Published: 14 June 2024
In the original publication [1], support from Clinical Trials Center of Incheon St. Mary’s Hospital, The Catholic University of Korea, was not included. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Sung, S.-Y.; Lee, S.-W.; Hong, J.H.; Kang, H.J.; Lee, S.J.; Kim, M.; Kim, J.-H.; Kwak, Y.-K. Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy. Cancers 2022, 14, 3749. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sung, S.-Y.; Lee, S.-W.; Hong, J.H.; Kang, H.J.; Lee, S.J.; Kim, M.; Kim, J.-H.; Kwak, Y.-K. Correction: Sung et al. Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy. Cancers 2022, 14, 3749. Cancers 2024, 16, 2220. https://doi.org/10.3390/cancers16122220

AMA Style

Sung S-Y, Lee S-W, Hong JH, Kang HJ, Lee SJ, Kim M, Kim J-H, Kwak Y-K. Correction: Sung et al. Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy. Cancers 2022, 14, 3749. Cancers. 2024; 16(12):2220. https://doi.org/10.3390/cancers16122220

Chicago/Turabian Style

Sung, Soo-Yoon, Sea-Won Lee, Ji Hyung Hong, Hye Jin Kang, So Jung Lee, Myungsoo Kim, Ji-Hoon Kim, and Yoo-Kang Kwak. 2024. "Correction: Sung et al. Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy. Cancers 2022, 14, 3749" Cancers 16, no. 12: 2220. https://doi.org/10.3390/cancers16122220

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop